|
3
|
12
|
3oofB |
Crystal structure of human fxr in complex with 4-({(2s)-2-[2-(4-chlorophenyl)-5,6-difluoro-1h-benzimidazol-1-yl]-2-cyclohexylacetyl}amino)benzoic acid |
|
3
|
12
|
3omkB |
Crystal structure of human fxr in complex with (2s)-2-[2-(4-chlorophenyl)-5,6-difluoro-1h-benzimidazol-1-yl]-2-cyclohexyl-n-(2-methylphenyl)ethanamide |
|
3
|
13
|
3ommB |
Crystal structure of human fxr in complex with 4-({(2s)-2-[2-(4-chlorophenyl)-5,6-difluoro-1h-benzimidazol-1-yl]-2-cyclohexylacetyl}amino)-3-fluorobenzoic acid |
|
3
|
11
|
3olfB |
Crystal structure of human fxr in complex with 4-({(2s)-2-[2-(4-chlorophenyl)-5,6-difluoro-1h-benzimidazol-1-yl]-2-cyclohexylacetyl}amino)-3-methylbenzoic acid |
|
2
|
10
|
3ompC |
Fragment-based design of novel estrogen receptor ligands |
|
3
|
12
|
3ookB |
Crystal structure of human fxr in complex with 4-({(2s)-2-[2-(4-chlorophenyl)-5,6-difluoro-1h-benzimidazol-1-yl]-2-cyclohexylacetyl}amino)-3,5-difluorobenzoic acid |
|
2
|
11
|
3lmpC |
Crystal structure of the ppargamma-lbd complexed with a cercosporamide derivative modulator |
|
3
|
12
|
3l3xB |
Crystal structure of dht-bound androgen receptor in complex with the first motif of steroid receptor coactivator 3 |
|
3
|
12
|
3l3zB |
Crystal structure of dht-bound androgen receptor in complex with the third motif of steroid receptor coactivator 3 |
|
3
|
10
|
3kmrC |
Crystal structure of raralpha ligand binding domain in complex with an agonist ligand (am580) and a coactivator fragment |
|
4
|
15
|
3ipqB |
X-ray structure of gw3965 synthetic agonist bound to the lxr-alpha |
|
5
|
15
|
3ipuC |
X-ray structure of benzisoxazole urea synthetic agonist bound to the lxr-alpha |
|
40
|
109
|
3io2A |
Crystal structure of the taz2 domain of p300 |
|
4
|
15
|
3ipsC |
X-ray structure of benzisoxazole synthetic agonist bound to the lxr-alpha |
|
113
|
317
|
3hvlA |
Tethered pxr-lbd/src-1p complexed with sr-12813 |
|
43
|
114
|
3i3jA |
Crystal structure of the bromodomain of human ep300 |
|
3
|
11
|
3hc5B |
Fxr with src1 and gsk826 |
|
2
|
11
|
3hc6B |
Fxr with src1 and gsk088 |
|
37
|
107
|
3gg3A |
Crystal structure of the bromodomain of human pcaf |
|
2
|
10
|
3gyuB |
Nuclear receptor daf-12 from parasitic nematode strongyloides stercoralis in complex with its physiological ligand dafachronic acid delta 7 |
|
2
|
10
|
3gytB |
Nuclear receptor daf-12 from parasitic nematode strongyloides stercoralis in complex with its physiological ligand dafachronic acid delta 4 |
|
0
|
11
|
3h0aB |
Crystal structure of peroxisome proliferator-activated receptor gamma (pparg) and retinoic acid receptor alpha (rxra) in complex with 9-cis retinoic acid, co-activator peptide, and a partial agonist |
|
2
|
13
|
3fxvB |
Identification of an n-oxide pyridine gw4064 analogue as a potent fxr agonist |
|
2
|
10
|
3g9eB |
Aleglitaar. a new. potent, and balanced dual ppara/g agonist for the treatment of type ii diabetes |
|
2
|
8
|
3g8iZ |
Aleglitazar, a new, potent, and balanced ppar alpha/gamma agonist for the treatment of type ii diabetes |
|
3
|
12
|
3furH |
Crystal structure of pparg in complex with int131 |
|
2
|
10
|
3fejB |
Design and biological evaluation of novel, balanced dual ppara/g agonists |
|
2
|
8
|
3feiZ |
Design and biological evaluation of novel, balanced dual ppara/g agonists |
|
4
|
16
|
3et3P |
Structure of ppargamma with 3-[5-methoxy-1-(4-methoxy-benzenesulfonyl)-1h-indol-3-yl]-propionic acid |
|
2
|
15
|
3et1P |
Structure of pparalpha with 3-[5-methoxy-1-(4-methoxy-benzenesulfonyl)-1h-indol-3-yl]-propionic acid |
|
40
|
114
|
3dwyA |
Crystal structure of the bromodomain of human crebbp |
|
2
|
11
|
3dr1B |
Side-chain fluorine atoms of non-steroidal vitamin d3 analogs stabilize helix 12 of vitamin d receptor |
|
2
|
11
|
3dctB |
Fxr with src1 and gw4064 |
|
3
|
11
|
3dcuB |
Fxr with src1 and gsk8062 |
|
41
|
111
|
3d7cA |
Crystal structure of the bromodomain of human gcn5, the general control of amino-acid synthesis protein 5-like 2 |
|
100
|
364
|
3cz7A |
Molecular basis for the autoregulation of the protein acetyl transferase rtt109 |
|
2
|
16
|
3cwdC |
Molecular recognition of nitro-fatty acids by ppar gamma |
|
113
|
317
|
3ctbA |
Tethered pxr-lbd/src-1p apoprotein |
|
3
|
11
|
3bqdB |
Doubling the size of the glucocorticoid receptor ligand binding pocket by deacylcortivazol |
|
101
|
378
|
3biyA |
Crystal structure of p300 histone acetyltransferase domain in complex with a bisubstrate inhibitor, lys-coa |
|
1
|
11
|
3bejE |
Structure of human fxr in complex with mfa-1 and co-activator peptide |
|
83
|
276
|
3aadA |
Structure of the histone chaperone cia/asf1-double bromodomain complex linking histone modifications and site-specific histone eviction |
|
100
|
408
|
2zfnA |
Self-acetylation mediated histone h3 lysine 56 acetylation by rtt109 |
|
73
|
273
|
2y0mA |
Crystal structure of the complex between dosage compensation factors msl1 and mof |
|
32
|
121
|
2rnyA |
Complex structures of cbp bromodomain with h4 ack20 peptide |
|
6
|
92
|
2ro0A |
Solution structure of the knotted tudor domain of the yeast histone acetyltransferase, esa1 |
|
100
|
406
|
2rimA |
Crystal structure of rtt109 |
|
31
|
118
|
2rnwA |
The structural basis for site-specific lysine-acetylated histone recognition by the bromodomains of the human transcriptional co-activators pcaf and cbp |
|
31
|
118
|
2rnxA |
The structural basis for site-specific lysine-acetylated histone recognition by the bromodomains of the human transcriptional co-activators pcaf and cbp |
|
4
|
94
|
2rnzA |
Solution structure of the presumed chromodomain of the yeast histone acetyltransferase, esa1 |
